Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

146.4K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
146.4K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
ATP Energy Storage and Release01:31

ATP Energy Storage and Release

14.0K
ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...
14.0K
Functional Groups02:45

Functional Groups

87.8K
Functional groups are a group of atoms with characteristic properties, which when linked to the carbon skeleton of a molecule, alter the properties of that molecule. For example, the presence of certain functional groups on a molecule will make them hydrophilic, whereas others will make them hydrophobic. These functional groups are an indispensable part of organic chemistry and important components of biological molecules, such as carbohydrates, proteins, lipids, and nucleic acids. Each...
87.8K
Functional Groups02:45

Functional Groups

24.2K
24.2K
Mechanical Protein Functions01:58

Mechanical Protein Functions

5.5K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force. 
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of beta2-adrenergic receptor knockout mouse model during Chlamydia muridarum genital infection.

Pathogens and disease·2024
Same author

Effects of prime-boost strategies on the protective efficacy and immunogenicity of a PLGA (85:15)-encapsulated Chlamydia recombinant MOMP nanovaccine.

Pathogens and disease·2024
Same author

PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in Mice.

International journal of nanomedicine·2024
Same author

The curious case of a sterically crowded Stenhouse salt.

Chemical science·2022
Same author

The Yucatan minipig model: A new preclinical model of malnutrition induced by a low-calorie/low-protein diet.

Clinical nutrition (Edinburgh, Scotland)·2022
Same author

Examination of Cutaneous Changes Among Patients Following SARS-CoV-2 Infection.

Cureus·2022

Related Experiment Video

Updated: Jan 21, 2026

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

23.5K

Prolonged Release and Functionality of Interleukin-10 Encapsulated within PLA-PEG Nanoparticles.

Skyla A Duncan1, Saurabh Dixit1, Rajnish Sahu1

  • 1Center for NanoBiotechnology & Life Sciences Research, Department of Biological Sciences, Alabama State University, 915 South Jackson Street, Montgomery, AL 36104, USA.

Nanomaterials (Basel, Switzerland)
|July 31, 2019
PubMed
Summary

We encapsulated anti-inflammatory interleukin-10 (IL-10) into nanoparticles to extend its therapeutic half-life. This novel approach shows potential for treating chlamydial infections and other inflammatory diseases.

Keywords:
IL-10PLA-PEG nanoparticlesSOCS1SOCS3anti-inflammatorychlamydiacytokinesinflammationrecombinant major outer membrane protein (rMOMP)therapy

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.5K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.0K

Related Experiment Videos

Last Updated: Jan 21, 2026

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

23.5K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.5K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.0K

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Nanotechnology

Background:

  • Inflammation is key in chlamydial infections, with interleukin-10 (IL-10) showing anti-inflammatory properties.
  • Clinical use of IL-10 is limited by its short half-life.

Purpose of the Study:

  • To prolong the half-life of IL-10 by encapsulating it in Poly (lactic acid)-Poly (ethylene glycol) (PLA-PEG) nanoparticles.
  • To evaluate the characteristics and efficacy of IL-10 loaded nanoparticles.

Main Methods:

  • IL-10 was encapsulated into PLA-PEG nanoparticles.
  • Nanoparticle characterization included size, zeta potential, and polydispersity index.
  • In vitro release studies, thermal stability analysis (differential scanning calorimetry), and macrophage assays were performed.

Main Results:

  • Encapsulated IL-10 nanoparticles exhibited a size of ~238 nm, zeta potential of -14.2 mV, and encapsulation efficiency of ~77%.
  • A sustained release of IL-10 was observed for up to 60 days with favorable thermal stability up to 89 °C.
  • Encapsulated IL-10 modulated inflammatory cytokine release (IL-6, IL-12p40) and induced SOCS1/SOCS3 in macrophages.

Conclusions:

  • PLA-PEG nanoparticles successfully prolonged IL-10 half-life and maintained its bioactivity.
  • Encapsulated IL-10 demonstrates significant potential for treating chlamydial inflammatory diseases and other biomedical applications.